• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 P2X 嘌呤受体激活在人输精管收缩性中的作用的展望。

Perspective on the role of P2X-purinoceptor activation in human vas deferens contractility.

机构信息

King’s College London, Guys Campus, London SE1 1UL, UK.

出版信息

Exp Physiol. 2012 May;97(5):583-602. doi: 10.1113/expphysiol.2011.063206. Epub 2012 Jan 6.

DOI:10.1113/expphysiol.2011.063206
PMID:22227201
Abstract

The contractile actions of α,β-methylene ATP (α,β-meATP) and ATP and the effects of K(+) channel blockers in longitudinal and circular muscles of human vas deferens were investigated with a view to clarifying the functional importance of P2X(1)-purinoceptor activation and K(+) channels in modulating contractility of the tissues. The results provide an experiment-based perspective for resolving differing reports on purinergic activation of the tissues and uncertain roles of large-conductance Ca(2+)-activated K(+) (BK(Ca)) and voltage-gated delayed rectifier K(+) (K(V)) channels. α,β-Methylene ATP (3-100 μm) evoked suramin-sensitive contractions of longitudinal muscle but rarely of circular muscle. ATP (0.1-3 mm) less reliably activated only longitudinal muscle contractions. These were enhanced by ARL 67156 (100 μm), but a different ectonucleotidase inhibitor, POM 1, was ineffective. Both muscle types were unresponsive to ADP-βS (100 μm), a P2Y-purinoceptor agonist. Longitudinal muscle contractions in response to α,β-meATP were enhanced by FPL 64176 (1 μm), an L-type Ca(2+) agonist, TEA (1 mm), a non-specific K(+) channel blocker, 4-aminopyridine (0.3 mm), a selective blocker of K(V) channels, and iberiotoxin (0.1 μm), a selective blocker of BK(Ca) channels. Quiescent circular muscles responded to α,β-meATP reliably in the presence of FPL 64176 or iberiotoxin. Apamin (0.1 μm), a selective blocker of small conductance Ca(2+)-activated K(+) (SK(Ca)) channels had no effect in both muscle types. Y-27632 (1-10 μm) reduced longitudinal muscle contractions in response to α,β-meATP, suggesting involvement of Rho-kinase-dependent contractile mechanisms. The results indicate that P2X(1)-purinoceptor stimulation elicits excitatory effects that: (a) lead to longitudinal muscle contraction and secondary activation of 4-aminopyridine-sensitive (K(V)) and iberiotoxin-sensitive (BK(Ca)) K(+) channels; and (b) are subcontractile in circular muscle due to ancillary activation of BK(Ca) channels. The novel finding of differential action by P2X(1)-purinoceptor agonists in the muscle types has functional implication in terms of the purinergic contribution to overall contractile function of human vas deferens. The modulatory effects of K(V) and BK(Ca) channels following P2X(1)-purinoceptor activation may be pivotal in providing the crucial physiological mechanism that ensures temporal co-ordination of longitudinal and circular muscle contractility.

摘要

研究了α、β-亚甲基 ATP(α、β-meATP)和 ATP 在人输精管纵、环行肌中的收缩作用,以及 K(+)通道阻滞剂的作用,以期阐明 P2X(1)-嘌呤能受体激活和 K(+)通道在调节组织收缩中的功能重要性。研究结果为解决组织内嘌呤能激活的不同报道以及大电导钙激活钾(BK(Ca)) 和电压门控延迟整流钾(K(V)) 通道的不确定作用提供了基于实验的视角。α、β-亚甲基 ATP(3-100μm)诱发苏拉明敏感的纵行肌收缩,但很少诱发环形肌收缩。ATP(0.1-3mm)不太可靠地仅激活纵行肌收缩。这些收缩作用被 ARL 67156(100μm)增强,但另一种外核苷酸酶抑制剂 POM 1 无效。两种肌型对 ADP-βS(100μm)均无反应,ADP-βS 是一种 P2Y-嘌呤能受体激动剂。α、β-meATP 引起的纵行肌收缩作用被 FPL 64176(1μm)增强,FPL 64176 是一种 L 型钙(Ca(2+)) 激动剂,TEA(1mm)是一种非特异性 K(+)通道阻滞剂,4-氨基吡啶(0.3mm)是一种选择性 K(V)通道阻滞剂,iberiotoxin(0.1μm)是一种选择性 BK(Ca)通道阻滞剂。在 FPL 64176 或 iberiotoxin 存在下,静息的环形肌对 α、β-meATP 可靠地产生反应。apamin(0.1μm),一种小电导钙(Ca(2+)) 激活钾(SK(Ca)) 通道的选择性阻滞剂,对两种肌型均无作用。Y-27632(1-10μm)减少了 α、β-meATP 引起的纵行肌收缩,表明 Rho-激酶依赖性收缩机制的参与。结果表明,P2X(1)-嘌呤能受体刺激引起兴奋作用:(a)导致纵行肌收缩和继发性激活 4-氨基吡啶敏感(K(V)) 和 iberiotoxin 敏感(BK(Ca)) K(+)通道;(b)在环形肌中为亚收缩性,因为辅助激活了 BK(Ca) 通道。在两种肌型中,P2X(1)-嘌呤能受体激动剂的不同作用的新发现,在人输精管整体收缩功能的嘌呤能贡献方面具有功能意义。P2X(1)-嘌呤能受体激活后 K(V) 和 BK(Ca) 通道的调节作用可能是提供确保纵行和环形肌收缩时间协调性的关键生理机制的关键。

相似文献

1
Perspective on the role of P2X-purinoceptor activation in human vas deferens contractility.对 P2X 嘌呤受体激活在人输精管收缩性中的作用的展望。
Exp Physiol. 2012 May;97(5):583-602. doi: 10.1113/expphysiol.2011.063206. Epub 2012 Jan 6.
2
Modulation of adrenergic responses of human vas deferens by K+ channel inhibitors.钾通道抑制剂对人输精管肾上腺素能反应的调制。
Urology. 2010 Dec;76(6):1518.e7-12. doi: 10.1016/j.urology.2010.07.475. Epub 2010 Oct 8.
3
Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.Rho激酶抑制剂对大鼠附睾输精管收缩力的减弱作用。
Auton Autacoid Pharmacol. 2006 Apr;26(2):169-81. doi: 10.1111/j.1474-8673.2006.00367.x.
4
Comparative effects of T-type and L-type Ca(2+)-antagonists against noradrenaline-induced contractions of human vas deferens.比较 T 型和 L 型钙通道拮抗剂对人输精管去甲肾上腺素诱导收缩的作用。
BJU Int. 2010 Aug;106(4):578-85. doi: 10.1111/j.1464-410X.2009.09092.x. Epub 2009 Dec 11.
5
Effects of different types of K+ channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle.不同类型钾通道调节剂对豚鼠膀胱平滑肌自发性肌源性收缩的影响。
Acta Physiol Scand. 2001 Nov;173(3):323-33. doi: 10.1046/j.1365-201X.2001.00908.x.
6
Interaction of αβ-Methylene ATP with the Cholinergic Twitch Response in the Guinea-Pig Ileum.αβ-亚甲基ATP与豚鼠回肠胆碱能抽搐反应的相互作用
Pharmacology. 2016;97(5-6):277-81. doi: 10.1159/000444504. Epub 2016 Feb 26.
7
Mechanisms of alpha,beta-methylene atp-induced inhibition in rat ileal smooth muscle: involvement of intracellular Ca2+ stores in purinergic inhibition.α,β-亚甲基ATP诱导大鼠回肠平滑肌抑制的机制:细胞内钙库参与嘌呤能抑制作用。
Clin Exp Pharmacol Physiol. 2000 Oct;27(10):771-9. doi: 10.1046/j.1440-1681.2000.03334.x.
8
Contractile actions of L-type Ca2+ agonists in human vas deferens and effects of structurally different Ca2+ antagonists.L 型钙通道激动剂对人输精管收缩作用及不同结构类型钙拮抗剂的影响。
Eur J Pharmacol. 2010 Feb 10;627(1-3):285-94. doi: 10.1016/j.ejphar.2009.10.043. Epub 2009 Oct 28.
9
Contractions mediated by alpha 1-adrenoceptors and P2-purinoceptors in a cat colon circular muscle.猫结肠环行肌中由α1-肾上腺素能受体和P2-嘌呤能受体介导的收缩
Br J Pharmacol. 1994 Aug;112(4):1237-43. doi: 10.1111/j.1476-5381.1994.tb13216.x.
10
Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens.Rho激酶的表达及其在小鼠输精管收缩活动中的功能作用。
Br J Pharmacol. 2003 Oct;140(4):743-9. doi: 10.1038/sj.bjp.0705479. Epub 2003 Sep 22.

引用本文的文献

1
Structural basis of the multiple ligand binding mechanisms of the P2X1 receptor.P2X1受体多重配体结合机制的结构基础
Acta Pharmacol Sin. 2025 Apr 2. doi: 10.1038/s41401-025-01512-y.
2
Insights on Platelet-Derived Growth Factor Receptor α-Positive Interstitial Cells in the Male Reproductive Tract.对男性生殖管道中血小板衍生生长因子受体 α 阳性间质细胞的认识。
Int J Mol Sci. 2024 Apr 8;25(7):4128. doi: 10.3390/ijms25074128.
3
The P2X1 receptor as a therapeutic target.P2X1 受体作为治疗靶点。
Purinergic Signal. 2022 Dec;18(4):421-433. doi: 10.1007/s11302-022-09880-4. Epub 2022 Jul 11.
4
Identification of PDGFRα-positive interstitial cells in the distal segment of the murine vas deferens.鉴定小鼠输精管远段 PDGFRα 阳性细胞间质细胞。
Sci Rep. 2021 Apr 6;11(1):7553. doi: 10.1038/s41598-021-87049-6.
5
POM-1 inhibits P2 receptors and exhibits anti-inflammatory effects in macrophages.POM-1 抑制 P2 受体并在巨噬细胞中表现出抗炎作用。
Purinergic Signal. 2017 Dec;13(4):611-627. doi: 10.1007/s11302-017-9588-x. Epub 2017 Oct 11.
6
A commonly used ecto-ATPase inhibitor, ARL-67156, blocks degradation of ADP more than the degradation of ATP in murine colon.一种常用的胞外ATP酶抑制剂ARL-67156,在小鼠结肠中对ADP降解的阻断作用比对ATP降解的阻断作用更强。
Neurogastroenterol Motil. 2016 Sep;28(9):1370-81. doi: 10.1111/nmo.12836. Epub 2016 Apr 5.
7
The purinergic neurotransmitter revisited: a single substance or multiple players?嘌呤能神经递质再探讨:单一物质还是多个参与者?
Pharmacol Ther. 2014 Nov;144(2):162-91. doi: 10.1016/j.pharmthera.2014.05.012. Epub 2014 Jun 2.
8
Purinergic signalling in the reproductive system in health and disease.健康与疾病状态下生殖系统中的嘌呤能信号传导
Purinergic Signal. 2014 Mar;10(1):157-87. doi: 10.1007/s11302-013-9399-7. Epub 2013 Nov 23.
9
Physiological and pharmacological aspects of the vas deferens-an update.输精管的生理和药理学方面的研究进展。
Front Pharmacol. 2013 Aug 22;4:101. doi: 10.3389/fphar.2013.00101. eCollection 2013.